Carl Koschmann Selected Research

Carl Koschmann Research Topics

Disease

45	Neoplasms (Cancer) 04/2024 - 07/2014
39	Glioma (Gliomas) 04/2024 - 07/2014
12	Diffuse Intrinsic Pontine Glioma 02/2024 - 01/2017
12	Brain Neoplasms (Brain Tumor) 02/2024 - 02/2015
8	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 02/2015
2	Brain Stem Neoplasms (Brain Stem Tumor) 11/2023 - 01/2022
2	Carcinogenesis 01/2023 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 10/2016
2	Medulloblastoma 01/2018 - 01/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2024
1	Aneuploidy (Aneuploid) 01/2023
1	Bites and Stings (Sting) 11/2022
1	Body Weight (Weight, Body) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Headache (Headaches) 01/2022
1	Nausea 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Vomiting 01/2022
1	Ependymoma 10/2021
1	Plexiform Neurofibroma 12/2020
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2020
1	Genomic Instability 01/2019
1	Intellectual Disability (Idiocy) 01/2019
1	Craniopharyngioma (Craniopharyngiomas) 01/2019
1	alpha-Thalassemia 01/2019
1	Melanoma (Melanoma, Malignant) 10/2016

Drug/Important Bio-Agent (IBA)

15	dipinacoline glutamateIBA 02/2024 - 01/2017
12	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2015
9	Histones (Histone)IBA 04/2024 - 01/2017
9	TIC10 compoundIBA 02/2024 - 01/2020
8	RNA (Ribonucleic Acid)IBA 06/2023 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2016
5	Circulating Tumor DNAIBA 11/2023 - 01/2018
3	Lysine (L-Lysine)FDA Link 04/2024 - 01/2023
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2022 - 01/2019
2	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 04/2024 - 09/2023
2	Methionine (L-Methionine)FDA Link 04/2024 - 09/2023
2	purineIBA 04/2024 - 09/2023
2	CytokinesIBA 11/2023 - 11/2022
2	ChromatinIBA 11/2022 - 01/2017
2	Everolimus FDA Link 10/2020 - 05/2019
2	Bevacizumab (Avastin)FDA Link 01/2018 - 07/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 07/2014
1	Dihydrotachysterol (AT 10)IBA 03/2024
1	chaetocinIBA 11/2023
1	Oncogene Proteins (Oncogene Protein)IBA 11/2023
1	Nucleosomes (Nucleosome)IBA 11/2023
1	ChemokinesIBA 11/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	HypoxanthineIBA 09/2023
1	EnzymesIBA 09/2023
1	GuanineIBA 09/2023
1	TransferasesIBA 09/2023
1	CannabidiolIBA 01/2023
1	ElementsIBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	minaprine (Cantor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Tricarboxylic AcidsIBA 10/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2021
1	PanobinostatIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020
1	Androgen Antagonists (Antiandrogens)IBA 10/2020
1	SteroidsIBA 10/2020
1	Androgen Receptors (Androgen Receptor)IBA 10/2020
1	Dasatinib (BMS 354825)FDA Link 10/2020
1	Hormones (Hormone)IBA 10/2020
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2020
1	alpha-hydroxyglutarateIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	1-methyltryptophanIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2019
1	CateninsIBA 01/2019
1	Therapeutic UsesIBA 01/2018
1	AntibodiesIBA 01/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	TensinsIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	NucleotidesIBA 03/2016
1	Histone ChaperonesIBA 03/2016
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 07/2014
1	Angiogenesis InhibitorsIBA 07/2014

Therapy/Procedure

22	Therapeutics 02/2024 - 07/2014
8	Radiotherapy 01/2024 - 10/2016
6	Drug Therapy (Chemotherapy) 01/2023 - 10/2016
5	Immunotherapy 03/2024 - 10/2016
3	Precision Medicine 01/2022 - 10/2017
1	Injections 07/2014